WallStSmart
TARA

Protara Therapeutics Inc

NASDAQ: TARA · HEALTHCARE · BIOTECHNOLOGY

$5.33
+3.09% today

Updated 2026-04-30

Market cap
$273.67M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$3 – $8
Volume
1.0M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Protara Therapeutics Inc (TARA) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Cash flow — annual

Item20122013201420152016201720182019202020212022202320242025
Operating cash flow$-8.23M$-6.70M$-9.99M$-17.57M$-23.69M$-22.35M$-23.23M$-15.65M$-23.41M$-34.50M$-26.46M$-37.56M$-35.81M$-56.37M
Capital expenditures$67000.00$10000.00$51000.00$198000.00$271000.00$35000.00$119000.00$16000.00$884000.00$596000.00$120000.00$45000.00$63000.00$94000.00
Depreciation$57000.00$27000.00$30000.00$57000.00$123000.00$148000.00$115000.00$279000.00$196000.00$117000.00$248000.00$341000.00$332000.00—
Stock-based comp——$459000.00$2.16M$3.34M$925.00$3.43M$943000.00$9.75M$10.36M$6.69M$6.09M$4.13M$3.83M
Free cash flow$-8.30M$-6.71M$-10.04M$-17.76M$-23.96M$-22.39M$-23.35M$-15.66M$-24.29M$-35.10M$-26.58M$-37.60M$-35.87M$-56.46M
Investing cash flow$7.38M$2.73M$-12.48M$-11.33M$19.92M$-16.10M$18.43M$2.48M$2.83M$-98.19M$14.95M$53.11M$19.16M—
Financing cash flow$-9000.00$4.36M$88.52M$163000.00$208000.00$23.05M$2.98M$500000.00$189.40M$-228000.00$-90000.00$-91000.00$139.87M—
Dividends paid——————————————
Share repurchases——————————————
Debt repayment——————————————
Net change in cash——$66.05M$-28.81M$-3.64M$-15.22M$-1.82M$-13.16M$168.83M—————